When it comes to effectively managing type 2 diabetes and weight loss medications, the selection of the appropriate medication plays a crucial role
Novo Nordisks Cagrilintide shows promising weight loss in REDEFINE-1 sub-analysis, unveiled at EASD 2025 Novo Nordisk presented new phase 3 data on cagrilintide, a once-weekly amylin analogue, at the European Association for the Study of Diabetes (EASD) congress which is happening in Vienna, Austria from 15 to 19 September 2025
GLP-1 (glucagon-like peptide-1) is a gut hormone that regulates appetite, gastric emptying, and insulin secretion
Sin embargo, este tratamiento experimental (L-carnitina) increment el peso del huevo (63.35 vs 65.68 g) con relacin a la dieta control (P 0.05) la altura del albumen, unidad Haugh, resistencia a la ruptura de la cscara y color de la yema
Nie Q, Luo X, Wang K, Ding Y, Jia S, Zhao Q, et al